Hematology · GLRX5-Related Sideroblastic Anemia

The Biology of the Iron-Sulfur Spark Plug

At a Glance

GLRX5-related sideroblastic anemia is an inherited disorder in which changes in GLRX5 disrupt mitochondrial iron-sulfur clusters needed for heme production. Iron then builds up in developing red blood cells, forming ring sideroblasts in the bone marrow.

To understand GLRX5-related sideroblastic anemia, it helps to think of the red blood cell as a factory that builds heme (the oxygen-carrying part of blood). In this condition, the factory has plenty of raw materials—specifically iron—but a critical piece of machinery called GLRX5 is not working.

The Biological Breakdown

GLRX5 is a protein that lives in the mitochondria, which are the power plants of the cell. Its job is to help build and move iron-sulfur [Fe-S] clusters ^[1]^[2]. These clusters are like “spark plugs” that activate other proteins needed to make heme.

When the GLRX5 gene has a pathogenic variant (mutation), several things go wrong in the cellular factory:

Broken Tools: Proteins like ferrochelatase (the tool that puts iron into heme) cannot get the iron-sulfur “spark plugs” they need to function ^[3]^[4].
Impaired ALAS2: Another critical enzyme, ALAS2, may also be affected. ALAS2 uses a substrate called succinyl-CoA as a building block for heme synthesis; the impaired iron-sulfur cluster biogenesis disrupts downstream iron regulation and cellular function, altering ALAS2 activity ^[5]^[4].
The Iron Pile-Up: Because the factory can’t use the iron to make heme, the iron has nowhere to go. It begins to “pile up” inside the mitochondria ^[4]. When doctors look at the bone marrow under a microscope, they see this iron as a ring around the center of the cell—these are the ring sideroblasts ^[3].

Distinguishing GLRX5 from Other Genetic Types

Not all congenital (present from birth) sideroblastic anemias are the same. Your doctor likely used genetic testing to tell GLRX5 apart from these other types:

ALAS2 (X-Linked): This is the most common form. It is “X-linked,” meaning it primarily affects boys ^[6]. Unlike GLRX5, many people with ALAS2 mutations respond well to high doses of Vitamin B6 (pyridoxine) ^[7].
SLC25A38: This is another inherited form that often shows up very early in infancy. It tends to be a severe presentation and usually does not respond to Vitamin B6 ^[8]^[7].

Ruling Out “Acquired” Mimics

Sometimes, things in the environment can make a healthy person’s bone marrow look like they have a genetic condition. Doctors must rule these out when diagnosing GLRX5:

Toxins and Metals: Lead poisoning or exposure to certain drugs and alcohol can cause ring sideroblasts ^[9]^[10].
Nutritional Imbalances: A severe lack of copper or an excess of zinc (which blocks copper absorption) can mimic the marrow findings of GLRX5 ^[11]^[9].

GLRX5 vs. MDS

You may hear the term Myelodysplastic Syndrome (MDS) during your research. It is important to know that MDS with ring sideroblasts is clinically distinct:

MDS is typically an “acquired” disease, most common in older adults, though it can occur in children ^[12]. It is driven by somatic mutations (mutations that happen in the blood cells over time), such as a mutation in the SF3B1 gene ^[13].
GLRX5 is “congenital,” meaning it is written into the DNA from birth and is usually inherited from both parents ^[4]^[14].

Doctors distinguish these conditions through marrow morphology, cytogenetics (chromosome testing), and molecular testing. By confirming the GLRX5 pathogenic variants, your medical team has identified the specific defect in your cellular factory, allowing them to focus on a tailored care plan.

Common questions in this guide

What is GLRX5-related sideroblastic anemia?

GLRX5-related sideroblastic anemia is an inherited blood disorder caused by harmful changes in the GLRX5 gene. These changes interfere with mitochondrial iron-sulfur clusters, which help cells make heme, the oxygen-carrying part of hemoglobin. Iron then accumulates in developing red blood cells and forms ring sideroblasts in the bone marrow.

Why do GLRX5 changes cause iron to build up in the bone marrow?

GLRX5 helps build iron-sulfur clusters that activate proteins involved in heme production. When this process is impaired, an enzyme called ferrochelatase cannot work normally and iron cannot be incorporated efficiently into heme. The unused iron collects in mitochondria around the cell center, creating ring sideroblasts.

What tests help diagnose GLRX5-related sideroblastic anemia?

Doctors combine bone marrow findings with chromosome testing and genetic testing. Finding disease-causing GLRX5 variants supports the inherited diagnosis, while testing helps distinguish it from myelodysplastic syndrome and from environmental or nutritional mimics. The medical team may also review family history and exposure to lead, alcohol, drugs, zinc, or copper deficiency.

How is GLRX5-related anemia different from ALAS2 or SLC25A38 disease?

ALAS2-related disease is X-linked, primarily affects boys, and often improves with high-dose vitamin B6. SLC25A38-related disease often begins in infancy, can be severe, and usually does not respond to vitamin B6. Genetic testing helps tell these inherited conditions apart from GLRX5-related disease.

How does GLRX5-related anemia differ from MDS with ring sideroblasts?

GLRX5-related sideroblastic anemia is congenital, meaning the gene change is present from birth and is usually inherited from both parents. MDS with ring sideroblasts is generally acquired over time and may involve changes such as SF3B1 mutations in blood cells. Bone marrow examination, chromosome testing, and molecular testing help distinguish the conditions.

Can lead exposure or low copper look like GLRX5-related anemia?

Yes. Lead and some drugs or alcohol can cause ring sideroblasts, while severe copper deficiency or excess zinc can produce similar bone marrow findings. Doctors consider these acquired causes so they do not mistake a potentially reversible mimic for an inherited GLRX5 disorder.

Get notified when new evidence is published on anemia, sideroblastic, 5.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (14)

1
Role of the HSPA9/HSC20 chaperone pair in promoting directional human iron-sulfur cluster exchange involving monothiol glutaredoxin 5.
Olive JA, Cowan JA
Journal of inorganic biochemistry 2018; (184()):100-107 doi:10.1016/j.jinorgbio.2018.04.007.
PMID: 29689452
2
Investigation of glutathione-derived electrostatic and hydrogen-bonding interactions and their role in defining Grx5 [2Fe-2S] cluster optical spectra and transfer chemistry.
Sen S, Bonfio C, Mansy SS, Cowan JA
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2018; (23(2)):241-252 doi:10.1007/s00775-017-1525-5.
PMID: 29264659
3
Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.
Liu G, Wang Y, Anderson GJ, et al.
Journal of cellular biochemistry 2016; (117(1)):207-17 doi:10.1002/jcb.25267.
PMID: 26100117
4
GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R, Mansouri A, Martelli A, et al.
Molecular genetics and metabolism 2019; (128(3)):342-351 doi:10.1016/j.ymgme.2018.12.012.
PMID: 30660387
5
Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K, Nicolas G, Schmitt C, et al.
Molecular genetics and metabolism 2019; (128(3)):190-197 doi:10.1016/j.ymgme.2019.01.015.
PMID: 30737140
6
Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M, Malcovati L
Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.
PMID: 26637696
7
Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.
Uminski K, Houston DS, Hartley JN, et al.
Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.
PMID: 32790119
8
Novel frameshift variant (c.409dupG) in SLC25A38 is a common cause of congenital sideroblastic anaemia in the Indian subcontinent.
Ravindra N, Athiyarath R, S E, et al.
Journal of clinical pathology 2021; (74(3)):157-162 doi:10.1136/jclinpath-2020-206647.
PMID: 32605921
9
When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.
Girard S, Genevieve F, Rault E, et al.
Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071752.
PMID: 35885655
10
[The 511th case: severe anemia with increased ringed sideroblasts].
Liu ZW, Chen M, Han B
Zhonghua nei ke za zhi 2025; (64(9)):906-910 doi:10.3760/cma.j.cn112138-20250616-00348.
PMID: 40904303
11
Zinc-induced copper deficiency, sideroblastic anemia, and neutropenia: A perplexing facet of zinc excess.
Wahab A, Mushtaq K, Borak SG, Bellam N
Clinical case reports 2020; (8(9)):1666-1671 doi:10.1002/ccr3.2987.
PMID: 32983473
12
[Silent α-Thalassemia Complicated with the Alcohol-Induced Secondary Ring Sideroblastic Anemia].
Jiang Y, Chen Y, Yang L, Li WB
Zhongguo shi yan xue ye xue za zhi 2025; (33(4)):1094-1097 doi:10.19746/j.cnki.issn.1009-2137.2025.04.024.
PMID: 40936135
13
Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.
Yoshimi A, Abdel-Wahab O
International journal of hematology 2017; (105(6)):720-731 doi:10.1007/s12185-017-2242-0.
PMID: 28466384
14
GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome.
Sankaran BP, Gupta S, Tchan M, et al.
Orphanet journal of rare diseases 2021; (16(1)):465 doi:10.1186/s13023-021-02073-z.
PMID: 34732213

This page explains the biology and diagnostic differences of GLRX5-related sideroblastic anemia for informational purposes only and does not constitute medical advice. Discuss genetic results, bone marrow findings, and possible mimics with your healthcare team.